{"id":"W4200232423","doi":"10.1186/s12962-021-00329-w","title":"First-line pembrolizumab plus chemotherapy for extensive-stage small-cell lung cancer: a United States-based cost-effectiveness analysis","year":2021,"lang":"en","type":"article","venue":"Cost Effectiveness and Resource Allocation","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"SKiN Health","funders":"Natural Science Foundation of Hunan Province; National Natural Science Foundation of China","keywords":"Medicine; Pembrolizumab; Lung cancer; Oncology; Public health; Health services research; Chemotherapy; Health administration; Health economics; Quality of Life Research; Stage (stratigraphy); Internal medicine; Cost effectiveness; Cancer; Immunotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008806554,0.0003848377,0.0009076789,0.0004907805,0.0004545142,0.0000833595,0.0001168181,0.0001600503,0.00003554754],"category_scores_gemma":[0.0003459461,0.0003353038,0.0002853091,0.00182356,0.0001759357,0.00006578819,0.00007747237,0.0002653589,0.000001224817],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001206413,"about_ca_system_score_gemma":0.0005364504,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001079125,"about_ca_topic_score_gemma":0.0004677842,"domain_scores_codex":[0.9973883,0.000551745,0.0003080401,0.0008415891,0.0003822722,0.0005280339],"domain_scores_gemma":[0.9956197,0.001986473,0.0001718686,0.0005181992,0.001456779,0.0002469397],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.03017376,0.001461923,0.1184724,0.02257343,0.008606455,0.0002026193,0.002187181,0.7484507,0.02034745,0.0001388742,0.0003503707,0.04703486],"study_design_scores_gemma":[0.03332194,0.0008796997,0.3153942,0.001505429,0.003488283,0.00001003931,0.0005781677,0.5486149,0.06383158,0.00002526339,0.03169558,0.0006549815],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8556843,0.007456278,0.1287403,0.001688917,0.0000823275,0.005983848,0.0001937637,0.0001074068,0.000062871],"genre_scores_gemma":[0.9899118,0.002473315,0.0001462972,0.0006564853,0.0001351311,0.004791382,0.00139539,0.00008236294,0.000407823],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1998358,"threshold_uncertainty_score":0.9999099,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03294104266757879,"score_gpt":0.3588166846572327,"score_spread":0.3258756419896539,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}